Gas Station Heroin: Tianeptine’s Immunomodulatory Effects on Central and Peripheral Tissues

Abstract

Purpose: Tianeptine, a tricyclic antidepressant targeting mu-opioid receptors, is approved in many countries but not in the U.S. While notorious for abuse risk, its immunomodulatory effects remain underexplored. This study examines: (1) dose-specific regulation of immune and inflammatory responses, and (2) effects across brain and peripheral immune cells.

Methods: We assessed cytotoxicity in RAW264.7 macrophages and SIM-A9 microglia using LDH assays across dilutions from 10 to 0.01953 μg/mL over 2 hours. After LPS challenge, baseline and post-/pre-treatment levels of TNF-α and IL-10 were measured via ELISA. Phagocytosis was evaluated by exposing cells to fluorescent E. coli and quantifying mean fluorescence intensity (FMI) as a measure of engulfment.

Results: Tianeptine exhibited a U-shaped cytotoxic profile in both cell types. Compared to LPS controls, IL-10 expression rose significantly while TNF-α levels dropped ~8-fold. Microglia (SIM-A9) showed greater IL-10 release than macrophages at equivalent doses; both exhibited comparable TNF-α suppression. Pre- and post-treatment with tianeptine further reduced inflammatory cytokines. Notably, phagocytic activity declined dose-dependently in RAW264.7 cells but increased in microglia.

Conclusions: These data reveal divergent immunomodulatory effects of tianeptine between peripheral macrophages and central microglia, with biphasic cytotoxicity and differential phagocytic responses. Future research should aim to clarify the receptor specific mechanisms of tianeptine’s immunomodulatory effect including the contributory factor of μ-opioid receptor signaling, and immunological consequences that may be relevant to the safety of tianeptine. Ultimately, this work adds more context to the expanding field of research investigating the immunological effects of psychiatric medications.